Evolution of Functional and Paraclinical Markers as Predictive Factors in Pediatric Late-Onset SMA Under Nusinersen Treatment: The Role of CSF pNF-H
Spinal Muscular Atrophy (SMA) is a rare neurodegenerative disease caused by insufficient synthesis of SMN protein, characterized by progressive muscle weakness, atrophy, and complications affecting the respiratory and digestive systems. Disease severity tends to be greater when symptoms manifest at...
Saved in:
Main Authors: | Mihaela Badina, Gabriel Cristian Bejan, Corina Sporea, Andrada Mirea |
---|---|
Format: | Article |
Language: | English |
Published: |
Romanian Association of Balneology, Editura Balneara
2025-12-01
|
Series: | Balneo and PRM Research Journal |
Subjects: | |
Online Access: | http://bioclima.ro/Balneo755.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive Clinical-Biological Markers Over the First 3 Years of Nusinersen Treatment in SMA Type 1 Patients
by: Mihaela Badina, et al.
Published: (2025-12-01) -
Successful pregnancy of an SMA type 3 sitter on Nusinersen therapy - a case report
by: Miriam Hiebeler, et al.
Published: (2025-01-01) -
Effect of nusinersen on pulmonary function in children with spinal muscular atrophy in the plateau region: A pilot study
by: Jicai Zhu, et al.
Published: (2025-01-01) -
Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy
by: Hüseyin Bahadır Şenol, et al.
Published: (2025-01-01) -
Clinicogenetic characterization and response to disease-modifying therapies in spinal muscular atrophy: real-world experience from a reference center in Southern Brazil
by: Ana Letícia Amorim de Albuquerque, et al.
Published: (2025-01-01)